Clarify-Leidos form alliance to enhance analytical insights via careC2
Date: 2020-01-14   Author: Saipriya Iyer  Category: #news

Clarify-Leidos form alliance to enhance analytical insights via careC2

Leidos, a global and FORTUNE® 500 leader in integrating information technology, has recently formed a strategic partnership with Clarify Health Solutions, a leader that delivers advanced health systems and solutions. The main aim behind the merger is to increase operations through its governance-based, world-class digital solutions in the healthcare setting. Under the agreement, analytical insights from Clarify can be delivered directly by customers via Leidos careC2 platform to carry out healthcare operations.

The careC2 is a modern platform that offers a secure, single, and real-time view of operations to ensure patients are receiving the right care at the right time. This solution is aimed at improving financial, clinical, and operational outcomes of patients in their health journey. The software also enables care coordination, bridges the capability gap and diversifies revenue so users can commercialize and design their own applications. Clarify’s analytics also consist of careC2 compliance, security, data services, and governance capabilities.

As stated by Todd Gottula, Clarify’s co-founder and Chief Product Officer, lending access and improving healthcare are key concerns for both companies to boost transparency and create extraordinary offerings in advanced analytics. The Health Group president of Leidos, Jon Scholl also believes the merger could help in identifying various growth avenues for healthcare analytics. Owing to these, healthcare partners will gain prominence as it continuously provides care for many patients.

Clarify Health’s inventions and insights are useful to carry out healthcare plans, systems, and life science companies to increase the care & treatment value offered to patients. It has collected a large patient-level dataset to glean analytical insights from world-class scientists, clinicians, engineers, and healthcare experts . Differentiated solution are obtained from the Clarify Health’s predictive insights through Leidos careC2.

In order to meet the needs of new customers, Clarify and Leidos are  jointly working on plans to deliver technologically-driven  care to extract actionable insights from fractured or disparate data.

Source credit:

https://www.prnewswire.com/news-releases/leidos-and-clarify-health-announce-strategic-alliance-to-deliver-innovative-analytics-solutions-to-healthcare-partners-300986048.html



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Global Angular Contact Ball Bearings Industry Market – Porter’s Five Forces Strategy Analysis and Forecast 2025
Author: Sachin Pashte

The New Research Report on Global Angular Contact Ball Bearings Industry Market till 2025 added by Market Study Report LLC studies the current and upcoming Market Size, Share, Demand, Growth Trend and Forecast.

The research report on Angular...


Ladder Industry Market Projection By Key Players, Status, Growth, Revenue, SWOT Analysis Forecast 2025
Author: Sachin Pashte

Market Study Report adds new report on Global Ladder Industry Market analysis 2020-2025. The report focuses on global major leading industry players with information such as company profiles, end users/applications, product and specification.

<...


DNA Repair Drugs Industry Market 2020 | Analysis by Industry Trends, Size, Share, Company Overview, Growth, Development and Forecast by 2025
Author: Sachin Pashte

Global DNA Repair Drugs Industry Market Report available at MarketStudyReport.com gives an industry overview of the DNA Repair Drugs Industry, which covers product scope, market revenue, opportunities, growth rate, sales volumes and figures. The r...